Enflurane hepatitis. A report of a case with a previous history of halothane hepatitis.
"Enflurane hepatitis" has only recently been accepted as a disease entity. As far as the authors know, this paper is the first report on enflurane hepatitis in a patient with a previous history of halothane hepatitis. Our conclusion is that a potent halogenated inhalation agent should never be given to a patient if a prior administration of another such agent has led to the development of hepatic injury.
D000328:Adult; D000777:Anesthetics / Q000009:adverse effects* / Q000378:metabolism; D001711:Biotransformation; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D004737:Enflurane / Q000009:adverse effects* / Q000378:metabolism; D005260:Female; D006221:Halothane / Q000009:adverse effects; D006801:Humans
D000777:Anesthetics; D004737:Enflurane; D006221:Halothane